A longitudinal investigation of psychological morbidity in patients with ovarian cancer.
AffiliationAcademic Division of Clinical Psychology, School of Psychological Sciences, University of Manchester, Zochonis Building, Brunswick Street, Manchester M13 9PL, UK. firstname.lastname@example.org
MetadataShow full item record
AbstractOvarian cancer patients may experience psychological disorders due to the aggressive nature of the illness and treatment. We investigated the presence of psychological disorders longitudinally in women with a new diagnosis of ovarian cancer and the factors that predicted development and maintenance of these disorders. Patients were assessed in a prospective longitudinal study at the beginning of chemotherapy treatment, mid-treatment, end of treatment and 3 months follow-up for depression, anxiety, perceived social support, neuroticism and cognitive strategies to control unwanted thoughts. A total of 121 patients were recruited and 85 patients were assessed at all four time points. Three different longitudinal profiles of anxiety and depression caseness were found: non-cases (never cases), occasional cases (cases on at least one but not all four occasions) and stable cases (cases on all four occasions). Most of the women were occasional cases of anxiety (52%, 44), whereas for depression, the majority of women were non-cases (55%, 47). A subset of patients were stable cases of anxiety (22%, 19). Neuroticism and marital status were significant independent predictors of anxiety caseness profile. Neuroticism and use of anti-depressants were independent predictors of depression caseness profile. Social support was not related to psychological morbidity.
CitationA longitudinal investigation of psychological morbidity in patients with ovarian cancer. 2008, 99 (11):1794-801 Br. J. Cancer
JournalBritish Journal of Cancer
- Social support, anxiety and depression after chemotherapy for ovarian cancer: a prospective study.
- Authors: Hipkins J, Whitworth M, Tarrier N, Jayson G
- Issue date: 2004 Nov
- Predictors of depression and anxiety symptom trajectories in the 24 months following diagnosis of breast or gynaecologic cancer.
- Authors: Stafford L, Komiti A, Bousman C, Judd F, Gibson P, Mann GB, Quinn M
- Issue date: 2016 Apr
- Mental distress, quality of life and social support in recurrent ovarian cancer patients during active chemotherapy.
- Authors: Wen Q, Shao Z, Zhang P, Zhu T, Li D, Wang S
- Issue date: 2017 Sep
- Coping strategies, trajectories, and their associations with patient-reported outcomes among women with ovarian cancer.
- Authors: Beesley VL, Smith DD, Nagle CM, Friedlander M, Grant P, DeFazio A, Webb PM, OPAL Study Group.
- Issue date: 2018 Dec
- Depression, anxiety, and quality of life in patients with epithelial ovarian cancer.
- Authors: Bodurka-Bevers D, Basen-Engquist K, Carmack CL, Fitzgerald MA, Wolf JK, de Moor C, Gershenson DM
- Issue date: 2000 Sep